•  
  •  
  •  
  •  

2025-12-23 10:32:33

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE08U801020

Stock Report

  • SAMHI receives MIDC Confirmation for an Extension to Develop Landmark Dual-Branded Hotel in Mumbai Metropolitan Region
  • SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
  • SAMHI Hotels Limited opens new hotel under the brand name 'Holding Inn Express' in Kolkata
  • SAMHI Hotels and GIC announce a strategic partnership for an Upscale+ hotel investment platform in India with an equity investment plan of up to ~US$300mn
  • SAMHI Hotels Limited opens new hotel in Greater Noida
  • SAMHI Hotels announces Strategic Acquisition of operating hotel in Whitefield, Bengaluru
  • SAMHI Reports Robust Q4 FY24 Growth, Charts Course for a Promising FY25 Performance
  • SAMHI Hotels Ltd closed at 17% premium to its issue price of Rs 126 per share

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024